Philip Ross talks about the outlook for M&A in our industry, and describes the pharma revenue growth demands that will be driving it. He discusses what qualities make targets attractive, and how the industry has changed over time during the course of his career. Plus, what attracted him to Jefferies.
View all episodes
By BiotechTV
5
44 ratings
Philip Ross talks about the outlook for M&A in our industry, and describes the pharma revenue growth demands that will be driving it. He discusses what qualities make targets attractive, and how the industry has changed over time during the course of his career. Plus, what attracted him to Jefferies.
110,845 Listeners
316 Listeners
30 Listeners
11 Listeners
4 Listeners
0 Listeners
2 Listeners
4 Listeners